'Maternal health staff office' presentation slideshows

One Year Post-Exclusivity Adverse Event Review: Ondansetron Pediatric Advisory Committee Meeting November 16, 2006

One Year Post-Exclusivity Adverse Event Review: Ondansetron Pediatric Advisory Committee Meeting November 16, 2006. Felicia L. Collins, MD, MPH, FAAP Medical Officer Pediatric and Maternal Health Staff Office of New Drugs Center for Drug Evaluation and Research Food and Drug Administration.

590 views • 27 slides

Food and Drug Administration Amendments Act of 2007 Reauthorization of Pediatric Initiatives

674 views • 18 slides